Kangji Medical lines up Hong Kong listing

By Jonathan Breen
30 Mar 2020

Mainland-based Kangji Medical Holdings is seeking approval to list in Hong Kong. It has filed an IPO application with the city’s bourse.

The medical device manufacturer submitted a draft prospectus on March 27 through sponsors Bank of America, CLSA and Goldman Sachs.

The issuer is China’s largest minimally invasive surgical instruments and accessories (MISIA) platform. By 2019 sales revenue, it ranked first among local manufacturers in the country’s Rmb18.5bn ($2.6bn) ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial